Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TGF-beta and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways

R H Weiss1, A P Yabes, R Sinaee

  • 1Department of Internal Medicine, Northern California System of Clinics, Pleasant Hill, USA.

Kidney International
|September 1, 1995
PubMed
Summary

Transforming growth factor-beta (TGF-beta) inhibits cell growth by activating protein kinase C (PKC), similar to phorbol esters. This suggests TGF-beta may be an endogenous activator of PKC, influencing cell proliferation and matrix production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.

Oncogene·2017
Same author

Kidney cancer: identification of novel targets for therapy.

Kidney international·2006
Same author

p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque.

Cellular signalling·2001
Same author

TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.

American journal of physiology. Endocrinology and metabolism·2001
Same author

The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.

Cellular signalling·2000
Same author

p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

The Journal of biological chemistry·2000

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) and phorbol-12-myristate-13-acetate (PMA) influence cell mitogenesis.
  • Phorbol esters activate protein kinase C (PKC), a known tumor promoter.
  • The role of PKC in TGF-beta's effects on cell growth is not fully understood.

Purpose of the Study:

  • To investigate if TGF-beta's growth inhibitory effects parallel those of phorbol esters.
  • To determine if TGF-beta's inhibition of mitogenesis is dependent on PKC activation.
  • To explore the potential role of TGF-beta as an endogenous activator of PKC.

Main Methods:

  • Vascular smooth muscle cells were stimulated with basic fibroblast growth factor (bFGF).
  • Cells were treated with TGF-beta1 or PMA to assess effects on mitogenesis.

Related Experiment Videos

  • Protein kinase C (PKC) translocation and expression levels were measured.
  • PKC was downregulated using PMA to evaluate its role in TGF-beta's effects.

    • Main Results:

    • TGF-beta1 inhibited bFGF-induced mitogenesis in a dose-dependent manner (up to 79%).
    • Both TGF-beta1 and PMA induced PKC translocation with similar time courses.
    • Downregulation of PKC abolished TGF-beta1's inhibitory effect on mitogenesis.
    • PKC-alpha and PKC-betaII levels were not increased by TGF-beta1.

    Conclusions:

    • TGF-beta utilizes a signaling pathway for mitogenesis inhibition that parallels PMA.
    • TGF-beta's inhibition of cell growth is partially mediated by PKC activation.
    • TGF-beta may act as an endogenous activator of the growth-inhibitory PKC pathway, potentially modulating extracellular matrix deposition.